EGFR and cancer: The results revealed that the most involved target genes are closely related to cancer pathways, including prostate cancer, proteoglycan in cancer, endocrine resistance, pancreatic cancer, PI3K-AKT signaling pathway, breast cancer, and EGFR tyrosine kinase inhibitor resistance (Figure 3B).